chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated that a few hours after he received the vaccine he got to burning on his insides and his b/p started dropping. His b/p was low for a week.  His legs have become weak and they will give out.  He was use to walking up to 3miles before he received the vaccine now he can barely walk.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with unspecified number of improperly stored VAQTA, (dose and route not provided) (lot number#L002717, expiration date: 02-JUN-2017, lot number #K002831, expiration date: 15-JAN-2016, lot number #K024697, expiration date: 28-APR-2017, or lot number #L004745, expired date 28-APR-2017). No adverse reports received from the same source. Additional information has been requested.
Pt vaccinated w/1st & 2nd dose of vax p/each dose experienced tenderness & pain @ inject site; Rec'd 3rd dose in SEP89 & experienced tenderness & chronic pain @ inject site;
This spontaneous report was received from a health care worker referring to an 11 year old male patient. No medical history was reported. Approximately on 22-DEC-2015, the patient was vaccinated with a dose of an improperly stored GARDASIL 9, dose, route and frequency: unknown, lot number: L016429, expiry date: 09-AUG-2017. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Stated that after vaccine was given he had a Dr appointment and at the office approximately 1.5-2 hours later he experienced syncope and passed out. When aroused by the staff at the MD office they took blood pressure and he stated it was fine.
Acute hives. Pt was treated in local hospital with BENADRYL and 0.3 mg/0.3 mL EPIPEN injectable.
Dizziness, brain fogginess for 45 minutes after shot. Symptoms slowly decreasing.
Developed severe headache 15 min after returning to class following vaccination . Approximately 30-40 min post vaccination FAther came to school and will transport his daughter to an Urgent care center for evaluation
antibody test negative after receiving 1st and 2nd dose of vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of ANTIBODY TEST NEGATIVE (antibody test negative after receiving 1st and 2nd dose of vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (antibody test negative after receiving 1st and 2nd dose of vaccine). At the time of the report, ANTIBODY TEST NEGATIVE (antibody test negative after receiving 1st and 2nd dose of vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Blood immunoglobulin G:. On 10-Mar-2021, Blood immunoglobulin M:.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Pt given 1 dose of Tetanus dipth tox vaccine at 14:57. Pt experienced seuzure witnessed at 15:56. Pt inadvertantly given 2nd dose at 16:26 and another seizure at 19:10.
A red circular mark around the injection site of an approximate diameter of 2 & 1/4".
Initial case was received from a healthcare professional on 06 November 2013. A female patient (age unknown) whose medical history and concomitant medication was not reported had received an intradermal FLUZONE, batch number: UT4726AA, dose and anatomical site of administration not reported) on an unspecified date. On an unknown date, the patient developed silver dollar size redness and swelling at the injection site. One patient experienced pain for 4 days at the injection site. Corrective treatments of laboratory investigations were not reported. The outcome of the event was unknown. This case is cross linked with other cases 2013SA117345, 2014SA012994 and 2014SA012995 being a same reporter. The list of documents held by sender: None. Follow up information was received from a healthcare professional on 10 March 2014. It was reported that the vaccine was administered at unknown site. The lab result was unknown. The outcome of the event was recovered at the time of report.
Pt woke up 5/22/08 with hives down the arm she received the vaccine on also her L side of her body.  No resp difficulty.
Pt recvd Engerix-B & 3-5 days p/inject dx w/serum sickness; sx included arthritis; fleety rash (extremities & chest); swollen joints; joint, bone, muscle pain; seen by MD concerning sx; 4MAR92 knees, ankles, wrists, swollen, red & hot;
Within 40-90 seconds after inoculation, left hand, wrist and arm curled up.  Her head went back and her eyes rolled to the back of her head. When talking with her she attempted to open her eyes which showed both eyes dilated.  She made a gurgle noise when her head initially went back.  Healthcare professionals then put her on the ground where she stayed for an hour.  While on the ground pt said her head hurt and was nauseated, dizzy, sweating, hot but also had goosebumps, pale, and she couldn't keep her eyes open.  Pt said she was trying to open her eyes but they wouldn't  stay open.  After about 45 minutes on the floor drinking water and eating soda crackers, Pt attempted to sit up but needed to lay back down due to being dizzy, nausea and weak.  At an hour Pt was able to sit up but was still very weak and tired.  Doctor refused to give medical exemption for the second dose.
Intially the injection site was very swollen,extremely painful and red from my shoulder to my elbow. I had fever and flu like symptoms. The flu like symptoms lasted about three days. The pain,swelling,fever and redness in my left arm continued for over a week. I went to see my nursing director (Iam a nursing student, that is why I recieved the immunization,in order to attend my clinical rotation). When I showed the injection site to my nursing director she said that it looked like reaction and that I needed to go back to my doctor and let her see it. I went back my doctor was'nt in so I showed it to the nurse,I made an appointment to see my doctor because the pain in my arm. I have constant pain and weakness in the arm and at this point nothing seems to help. I have tried heat, cold, Ibuprophen, Tramodol with Tylenol, and currently Mobic which isn't helping. I would like some answers and help to know is this going to get better or worse and what can I do about it.
Minor vaccine arm soreness- 3:00 pm of vaccination day Minor body aches- 9:00 pm of vaccination day; severe body aches- 5:00 am of next day; joint pain- 5:00 am of next day; hot flashes/chills- 5 am of next day; severe muscle pain/tightness- 5 am of next day. Side effects lasted through 9pm of next day. The symptoms started to decrease in severity around 3pm. 1000 mg of Tylenol was taken at 10pm night of vaccine, again at 11am of next day and again at 5 pm of next day.  Tylenol helped reduce the severe pain.
after her first dose of the vaccine she had a super sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 23Mar2021 (Lot number: ER2613) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 23Mar2021, outcome "recovered" (Mar2021), described as "after her first dose of the vaccine she had a super sore arm".  Additional information: Patient side effects began either the next day or that evening, it wasn't immediate. patient says that she couldn't sleep that evening because patient couldn't sleep on that side that night, so it must have begun that evening on 23Mar2021. It lasted about 3 days. Patient second dose of the vaccine on 13Apr2021.  No follow-up attempts are possible. No further information is expected.
Vaccine side swollen lymph nodes near collar bone; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Other medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced vaccine side swollen lymph nodes near collar bone. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vaccine side swollen lymph nodes near collar bone was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Since the second dose everything has been upper respiratory infections and ear infections every month.  He has already had he tonsils, removed before this dose, tubes put in his ears. The Upper Respiratory causes runny nose and breathing issues, not to be hospitalized but low. They cannot issue with what is causing the issues. It seems the common cold is causing him to be seen in the urgent care. He has been tested for everything, Flu, COVID-19, Pneumonia. He is another round of antibiotics and medications for upper respiratory infection and ear infections.
Patient came to community covid vaccine event on 4/13/2021 with her Mother who completed vaccine form for Pt. Pt was given 1st dose of Moderna vaccine on 4/13/2021. Pt returned on 5/11/2021 for her 2nd dose which was captured by this RN prior to getting 2nd dose.  RN informed Parent that Pt inadvertantley got covid vaccine that has not yet been approved for Pt age group. Parent stated she wanted Pt to get her 2nd dose anyway & that Pt did not experience any side effects or complaints after receiving first dose.
pt recvd flu vax 1030AM & 6PM onset jittery, nervous feeling tremulous in hands; felt weak, dizzy 17JAN93 pt reports still jittery filling but gradually subsiding;
Day 9 local 6X 4 inch  erythema with hardness. Stiffness with external rotation. No systemic reactions.
immediate right sided weakness which progressed to right sided leg ataxia and weakened right arm (unable to grip and hold utensils) video visit with internal medicine 1/28/2021, ordered stat brain MRI w/out contrast which was done 1/28/2021 ER on 1/29/2021 where they consulted Neurology and prescribed physical therapy, MRI cervical spine w and w/o contrast 2/1/2021 video visit with primary care and neurology visit same day with.  physical therapy started 2/2/2021
I EXPERIENCED A BURNING SENSATION AFTER URINATION FOR THE REMAINDER OF THE DAY YESTERDAY, AFTER I RECEIVED THE VACCINE.. I URINATED THIS MORNING AND THE SENSATION WENT AWAY.
Child was admitted to Hosp on 9MAR91 by MD for resp problems (apnea); D/C 13MAR91 & was fine;
Initial unsolicited report received from a consumer via other company (Pfizer) (Manufacturer Report Number: 2016479847) in on 31 October 2016. This case involves a 67-year-old female patient who was vaccinated with a dose of Flu shot and PNEUMONIA SHOT (batch number, expiration date and dose, dose in series, route of administration and site of administration were not reported for both vaccines) on an unspecified date. The patients' previous medications and medical history were not reported. On an unspecified date, following vaccination, the patient felt as patient was in a fog, like patient's pressure was up, cloud over patient's head was not feeling well. Laboratory investigations and corrective treatment was not reported. The patient outcome was not reported. Documents held by sender: none.
Dizziness, Headache, Myalgia, CHILLS, SORE THROAT Narrative:  Other Relevant History:
Full body rash with raised blisters. Started 8 days following injection.  Intense itching for 5 days, then began to subside, lasting an additional 6 days.  Skin peeled where rash had been, before returning to normal.  Self treated with antihistamines and menthol cream.  No doctor consultation.
Initial report received from a consumer who is the parent of the patient on 03 June 2013. An 11 year old male patient was administered MENACTRA, site, route, dose and batch number not reported on 07 July 2007. Concomitant medications and medical history were not reported. The patient did not have an illness at the time of vaccination and had no known allergies. The patient had an onset of a high fever (temperature not reported) and seizure on an unreported date and was seen in the ER. He was treated with IV ceftriaxone, dose not specified. He returned to the hospital later the same day and was kept for 3 days. A spinal tap was performed on an unreported date and was inconclusive. A head CT was negative on an unreported date. The patient recovered on an unreported date. Further details were not available at the time of this report. Documents held by sender: None.
my son has developed PE; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "my son has developed PE". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
3" diameter whelp (red and warm to touch) 2" below site of injection 2 days later. Recommended Pharmacy minute clinic or Urgent Care for possible infection.
pt devel abscess lt upper thigh w/incision & drainage;3cm of induration & erythema w/flatulence medially, tender;runny nose 2-3d, irritable;rubbing ears;lt thigh seems redder & bruised;
This case was reported by a physician and described the occurrence of erythema multiforme in a 15 year old female subject who was vaccinated with hepatitis A vaccine inactivated for prophylaxis. Medical history included migraine. On 8/3/05 the subject received the first dose of Havrix. On 8/3/05, the subject was also vaccinated with meningococcal polysaccharide conjugate vaccine (Menactra). On an unspecified date on or after 8/3/05 and on or before 8/22/05, less than one month after vaccination with Havrix, the subject experienced erythema multiforme, serum sickness, muscle pain, and fever. The subject was seen at a physician's office. The outcome of the events was not reported. Comment: Erythema multiforme was assessed as medically serious (OMIC).
Left Heal became gradually painful especially to weight bearing about 3 hours after vaccine.  No other symptoms.  24 hours latter it seems reddened somewhat compared to the right heal.  It is made worse with dorsiflexion of the foot or weight bearing.  It also appears a little swollen.  It does not feel warm to touch.  No sign of foreign body or history of any injury or new increased activity.
Headache; Dizziness; 102 Fahrenheit Fever; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 23May2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included prawn's allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ascorbic acid; calcium pantothenate; colecalciferol; cyanocobalamin; folic acid; nicotinamide; pyridoxine hydrochloride; retinol; riboflavin; thiamine hydrochloride; tocopheryl acetate (ONE A DAY MENS) from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 02May2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 03:00, the patient experienced headache, dizziness and a 102 Fahrenheit fever. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, dizziness and 102 Fahrenheit fever was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Rash; This is a spontaneous report from a non-contactable consumer (Patient) via Medical Information Team. A 60-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 15Apr2021 (at the age of 60-years), as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, patient took 1st dose of COVID-19 VACCINE. On 16Apr2021 (one day after vaccination), patient had rash. Patient wanted to know if she can take Benadryl for the rash. Patient stated that she received documentation that this normally happened within an hour, and now this reaction occurred one day later and was asking about any information on side effects. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Ongoing tinnitus in both ears.  Started in early hours of the morning the day after vaccination, waking me up and has persisted ever since.
I had started the bronchia cough nonstop. I took a home COVID-19 test just as a precaution. The home COVID-19 test did come back positive; I called my doctor to have a telehealth visit. We discussed my symptoms; I was prescribed the PAXLOVID. I started the medication immediately. The initial symptoms started to leave in a week. It did take over a month for me to get over COVID-19, I lost my sense of taste, my voice, I am just now starting to get my voice back.
Patient has Dementia and came in on his own, without wife, and said he didn't get his flu shot yet and filled out the paperwork, got the shot. I called his wife to let her know he had gotten a second flu shot and she was going to watch him for any issues.  I checked on him 3 days later and she said he was fine; nothing had happened in regard to an adverse event.  There were no adverse effects for the patient
Patient received PNEUMOVAX 23 on Tuesday, 9/14/10. He had previously received the flu shot. He experienced pain and swelling. This caused him to seek treatment from his doctor on Friday, 9/17.
Two days after I got the shot, I felt severe "brain fog" (disoriented) all day.  The third and fourth days after the shot, I felt severe dizziness at all times.   (I had seasonal allergies at the time - sneezing and runny nose, and my doctor thinks this affected my middle ear, causing the dizzy feeling.)
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown demographics. On an unspecified date, since 05-MAY-2014 an unspecified number of patients were vaccinated with PROQUAD. The reporter stated that on 05-MAY-2014 onwards her refrigerator and freezer units began to have temperature excursions and PROQUAD was improperly exposed to temperatures above 5F as listed in the following sentences. PROQUAD Lot #: K006219 (expiration: 29-OCT-2015) was improperly exposed to 22F for 2000 hours. All of the data listed here was reconfirmed with the reporter. No further information was available at the time of this report. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Numbness and tingling/warmth sensation in the left side of my face. This has still persisted slightly since starting after the vaccination with reduced sensation and tingling. I did not lose movement of the left side of my face.
In September I contracted Covid. I have had it before but this time it was worse, which was odd because I had 4 vaccines. Congestion, fever, extreme fatigue, sore throat and coughing. I called my doctor who put me on Paxlovid for 5 days. It gave me stomach discomfort and after the 5 days I was not recovering. I did a telehealth with the same doctor and noticed that I also had a secondary infection. A sinus infection had developed, and I was put on antibiotics. I am doing better now but am still nasally after a week has past and I am now testing negative.
Nausea; Tiredness; Headache; This case was reported by a consumer via call center representative and described the occurrence of nausea in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea, tiredness and headache. On an unknown date, the outcome of the nausea, tiredness and headache were recovered/resolved.   It was unknown if the reporter considered the nausea, tiredness and headache to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The patient enquired if she need to had the 2nd dose of Shingrix as she experienced side effects with the first dose.  The patient did not remember when she received the first dose but she experienced nausea, tiredness and headache the day following administration of the vaccine. Consent obtained to contact health care professional and consumer for follow-up The reporter consented to follow up.
pt recvd vax on 15nov94; pt had fallen 2 days prior & hurt Lt shoulder & neck; vax given lt deltoid;on 17nov94 spasm & tenderness of lt trapezius & neck muscle; quarter sized area of erythema surrounding inject site, minimal induration;
A nurse reported that an adult male, now 67 years of age, received an injection of Tetanus Toxoid in 1971. He subsequently became "bedridden for 4 days and almost comatose". He recovered.
Admitted to Hospital with COVID Symptoms. with cough, sob, fever, loss of taste and smell. COVID -19 positive. no other details provided in submitted Web report. patient was vaccinated Pfizer x2.